GSK Jan 2024 40.000 call
| Previous close | 0.0600 |
| Open | 0.1000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 40.00 |
| Expiry date | 2024-01-19 |
| Day's range | 0.0600 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Yahoo Finance Video
FTC warns pharma companies on excessive drug patenting
The Federal Trade Commission (FTC) issued warning letters to several pharmaceutical companies, including AbbVie (ABBV) AstraZeneca (AZN), and Teva (TEVA), over excessive patenting of medications as Medicare negotiates drug costs with the pharma industry. Yahoo Finance Health Reporter Anjalee Khemlani explains the Biden administration's ideas to license patents to lower drug costs for patients. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Fool.co.ukAt £14, the GSK share price looks like a top bargain to me
The GSK share price looks dirt cheap at the moment. But do the risks outweigh the potential reward with this FTSE 100 stock? The post At £14, the GSK share price looks like a top bargain to me appeared first on The Motley Fool UK.
Insider Monkey20 Countries with Free Health Care
In this article, we will be taking a look at the 20 countries with free health care. To skip our detailed analysis, you can go directly to see the 5 countries with free health care. The U.S. is one of the only advanced countries in the world to not have free healthcare, which is said […]
